STUDY: Novel “Triagonist” Retatrutide Resolved Steatosis in Over 85% of Patients with MASLD and Obesity
TLM 2023: In participants with metabolic dysfunction-associated steatotic liver disease, retatrutide 8 mg and 12 mg resolved steatosis in >85% of subjects.
Chronic Liver Disease Prevalence May Triple by Decade's End, New Report Projects
Driven largely by the widespread increase in diabetes and obesity, the rise in hepatic disease disparately affects minority populations and is outpacing available medical care.
When it Comes to the Monovalent COVID-19 Shot, the CDC and WHO Have a Disagreement
Should the monovalent COVID-19 vaccine approved for use this respiratory virus season be given universally or to only those at high risk? There are differences of opinion.
Tirzepatide Approved by FDA for Chronic Weight Management in Adults
The second GLP-1 mimetic-based drug approved for chronic weight management, tirzepatide may outperform semaglutide, the first.
The Exam Room's Secret Weapon for Flu Season
Physician author Terry Brenneman, MD, suggests a key difference between a great clinician and an average one, and it has to do with used car sales. Read more.
Obesity is a Key Risk Factor for Hypertension, but Comorbidities Complicate the Relationship
President of the Alabama Obesity Society, Dr Jonathan Parker, discusses obesity as a risk factor for hypertension.
Daily Dose: US Adults Don't Discuss OTC Pain Relievers with Clinicians Despite Hypertension Risk
Your daily dose of the clinical news you may have missed.
It's High Time to Retire NAFLD: Multinational Liver Societies Explain
NAFLD, a term coined in the mid-nineteenth century but never an accurate name for the diseases it now stands for, was ready to go, agreed international experts.
NAFLD is Now MASLD: The New Nomenclature, At-a-Glance
The shift in naming for diseases historically known as nonalcoholic fatty liver disease will be top of mind at The Liver Meeting 2023. Get a quick look at why.
Final Pearls and Takeaways for Testing and Managing CKD
Experts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
AI CKD Test Clinical Implementation and Provider Pearls
Robert Busch, MD, provides his approach on implementing artificial intelligence (AI) testing for chronic kidney disease and offers success stories of this testing and treatment approach.
Patients Trust Wearables and Want their HCPS to Trust Them, Too
Nearly 90% of patients are more likely to choose a doctor who incorporates wearable data into their health care plans, according to a new report.
Young Welder and Painter: Seen in the ED
The young patient's symptoms are nonspecific but there are questions that should be asked to help narrow the differential diagnosis - which ones?
The Liver Meeting 2023: AASLD Offers "Journey Maps" to Focused Areas of Interest
We took The Liver Meeting's 11 journey maps to educational sessions and focused on 4 that will be of interest to primary care.
Daily Dose: Variation in Post-ED Follow-Up Visits for Acute Bronchiolitis Across US States
Low Estimated Burden of Asthma in Low- and Middle-Income Countries Likely Reflects Underdiagnosis, Underreporting
A new meta-analysis found prevalence of asthma higher in countries with better air quality, higher income status, and health care access.
Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants
"We are Great Medical Home Neighbors," Says Pediatric PM&R Physician Amy Houtrow, MD, PhD, MPH
Collaboration among care team members is a key ingredient to effective support for children with disabilities and this specialist says her welcome mat is out for her neighbors.
Vaccination in America: Highs and Lows by State
Get a quick look at the 5 states ranking highest and lowest on metrics including flu vaccination, tetanus vaccination, HPV vaccination, and more.
Vonoprazan, Novel Treatment for Erosive Esophagitis, Gets FDA Nod
The novel potassium-competitive acid blocker is the first new treatment approved for the potentially cancer-producing GI disease in 30 years.
